This paper deals with Bayesian inference and prediction problems of the Burr type XII distribution based on progressive first failure censored data. We consider the Bayesian inference under a squared error loss function. We propose to apply Gibbs sampling procedure to draw Markov Chain Monte Carlo (MCMC) samples, and they have in turn, been used to compute the Bayes estimates with the help of importance sampling technique. We have performed a simulation study in order to compare the proposed Bayes estimators with the maximum likelihood estimators. We further consider two sample Bayes prediction to predicting future order statistics and upper record values from Burr type XII distribution based on progressive first failure censored data. The predictive densities are obtained and used to determine prediction intervals for unobserved order statistics and upper record values. A real life data set is used to illustrate the results derived
Competing risks data usually arises in studies in which the death or failure of an individual or an item may be classified into one of T≥2 mutually exclusive causes. In this paper, we will study the competing risks model when the data is progressively first-failure-censored. Based on this type of censoring, we derive the maximum likelihood estimators (MLE's) for the unknown parameters. Approximate confidence intervals and two bootstrap confidence intervals are also proposed. The results in the cases of first-failure censoring, progressive Type II censoring, Type II censoring and complete sample are special cases. A real data set has been analyzed for illustrative purposes. Different methods have been compared using Monte Carlo simulations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.